[P1] Poster Session 1 (Odd Numbers)

[P-13] Development of a highly safe and effective live attenuated SARS-CoV-2 vaccine based on temperature sensitivity-associated mutations

^○Shinya Okamura^1,2, Akiho Yoshida^1,2, Shiro Takekawa¹, Hirotaka Ebina^1,2,3 (1.The Research Foundation for Microbial Disease of Osaka University, Suita, Osaka, Japan, 2.Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, Japan, 3.6Virus Vaccine Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan)